128 related articles for article (PubMed ID: 25513028)
21. Use of total lymphocyte count for monitoring response to antiretroviral therapy.
Schreibman T; Friedland G
Clin Infect Dis; 2004 Jan; 38(2):257-62. PubMed ID: 14699459
[TBL] [Abstract][Full Text] [Related]
22. [Studies on the determinants and changes related to the natural CD4(+) T cell counts among antiretroviral treatment-naive HIV/AIDS patients in Dehong prefecture, Yunnan province].
Ye RH; Duan S; Xiang LF; Yang YC; Yang ZJ; Han WX; Cao DD; Yang JH; Li WM; Yang J; Wang JB; Gao J; Gong YR; Yang SJ; Zhu P; He N
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Sep; 32(9):882-7. PubMed ID: 22340875
[TBL] [Abstract][Full Text] [Related]
23. Total lymphocyte count as a surrogate marker to predict CD4 count in human immunodeficiency virus-infected children: a retrospective evaluation.
Wang Y; Li Y; Wang C; Liang S; Guo J; Li Z; Zhang M; Li W
Pediatr Infect Dis J; 2012 Jan; 31(1):61-3. PubMed ID: 22217967
[TBL] [Abstract][Full Text] [Related]
24. CDC staging based on absolute CD4 count and CD4 percentage in an HIV-1-infected Indian population: treatment implications.
Vajpayee M; Kaushik S; Sreenivas V; Wig N; Seth P
Clin Exp Immunol; 2005 Sep; 141(3):485-90. PubMed ID: 16045738
[TBL] [Abstract][Full Text] [Related]
25. Total lymphocyte count and hemoglobin combined to predict CD4 lymphocyte counts of less than 200 cells/mm(3) in HIV/AIDS.
Wilhan ; Budiono E
Acta Med Indones; 2008 Apr; 40(2):59-62. PubMed ID: 19054881
[TBL] [Abstract][Full Text] [Related]
26. Serum concentration of acute phase protein and lipid profile in HIV-1 seropositive patients and its relationship to the progression of the disease.
Ogunro PS; Idogun ES; Ogungbamigbe TO; Ajala MO; Olowu OA
Niger Postgrad Med J; 2008 Dec; 15(4):219-24. PubMed ID: 19169337
[TBL] [Abstract][Full Text] [Related]
27. Scaling up antiretroviral treatment services in Karnataka, India: impact on CD4 counts of HIV-infected people.
Shastri S; Boregowda PH; Rewari BB; Tanwar S; Shet A; Kumar AM
PLoS One; 2013; 8(8):e72188. PubMed ID: 23951294
[TBL] [Abstract][Full Text] [Related]
28. Correlation analysis on total lymphocyte count and CD4 count of HIV-infected patients.
Liu FR; Guo F; Ye JJ; Xiong CF; Zhou PL; Yin JG; Ye LX
Int J Clin Pract; 2008 Jun; 62(6):955-60. PubMed ID: 17983435
[TBL] [Abstract][Full Text] [Related]
29. CD4 lymphocyte percentage predicts disease progression in HIV-infected patients initiating highly active antiretroviral therapy with CD4 lymphocyte counts >350 lymphocytes/mm3.
Hulgan T; Raffanti S; Kheshti A; Blackwell RB; Rebeiro PF; Barkanic G; Ritz B; Sterling TR
J Infect Dis; 2005 Sep; 192(6):950-7. PubMed ID: 16107946
[TBL] [Abstract][Full Text] [Related]
30. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
[TBL] [Abstract][Full Text] [Related]
31. Performance of absolute CD4+ count in predicting co-infection with human T-lymphotropic virus type 1 in antiretroviral-naive HIV-infected patients.
Gudo ES; Bhatt NB; Augusto O; Semá C; Savino W; Ferreira OC; Jani IV
Int J STD AIDS; 2012 Oct; 23(10):717-23. PubMed ID: 23104746
[TBL] [Abstract][Full Text] [Related]
32. WHO clinical staging of HIV infection and disease, tuberculosis and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts.
Teck R; Ascurra O; Gomani P; Manzi M; Pasulani O; Kusamale J; Salaniponi FM; Humblet P; Nunn P; Scano F; Harries AD; Zachariah R
Int J Tuberc Lung Dis; 2005 Mar; 9(3):258-62. PubMed ID: 15786887
[TBL] [Abstract][Full Text] [Related]
33. CD4 and total lymphocyte counts as predictors of HIV disease progression.
Post FA; Wood R; Maartens G
QJM; 1996 Jul; 89(7):505-8. PubMed ID: 8759490
[TBL] [Abstract][Full Text] [Related]
34. Trends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.
Mutimura E; Addison D; Anastos K; Hoover D; Dusingize JC; Karenzie B; Izimukwiye I; Mutesa L; Nsanzimana S; Nash D;
AIDS; 2015 Jan; 29(1):67-76. PubMed ID: 25562492
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people.
Stebbing J; Sawleshwarkar S; Michailidis C; Jones R; Bower M; Mandalia S; Nelson M; Gazzard B
Postgrad Med J; 2005 Sep; 81(959):586-8. PubMed ID: 16143689
[TBL] [Abstract][Full Text] [Related]
36. Western blot banding patterns of HIV rapid progressors in the U.S. Navy Seropositive Cohort: implications for vaccine development. Navy Retroviral Working Group.
Garland FC; Garland CF; Gorham ED; Brodine SK
Ann Epidemiol; 1996 Jul; 6(4):341-7. PubMed ID: 8876845
[TBL] [Abstract][Full Text] [Related]
37. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
38. Finding patients eligible for antiretroviral therapy using TB services as entry point for HIV treatment.
Bwire R; Nagelkerke NJ; Borgdorff MW
Trop Med Int Health; 2006 Oct; 11(10):1567-75. PubMed ID: 17002731
[TBL] [Abstract][Full Text] [Related]
39. Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
Mocroft A; Staszewski S; Weber R; Gatell J; Rockstroh J; Gasiorowski J; Panos G; Monforte Ad; Rakhmanova A; Phillips AN; Lundgren JD;
Antivir Ther; 2007; 12(3):325-33. PubMed ID: 17591022
[TBL] [Abstract][Full Text] [Related]
40. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
